Amylyx Pharmaceuticals (AMLX) Market Capitalization (2022 - 2026)

Amylyx Pharmaceuticals has reported Market Capitalization for 5 years, with the latest figure at $2.0 billion in Q2 2026.

• On a quarterly basis, Market Capitalization rose 249.99% year-over-year to $2.0 billion in Q2 2026; TTM through Jun 2026 was $2.0 billion, a 249.99% increase from a year earlier, with the FY2025 full-year figure at $1.3 billion, up 411.68% from the prior year.
• Market Capitalization was $2.0 billion for Q2 2026 at Amylyx Pharmaceuticals, up from $1.5 billion in the prior quarter.
• The five-year high for Market Capitalization was $2.5 billion in Q4 2022, with the low at $129.4 million in Q2 2024.
• Average Market Capitalization over 5 years is $1.1 billion, with a median of $1.2 billion recorded in 2022.
• The sharpest annual moves came in 2024 and 2025: Market Capitalization plunged 91.1% in 2024, then soared 571.68% in 2025.
• Over 5 years, Market Capitalization stood at $2.5 billion in 2022, then slumped by 59.45% to $996.7 million in 2023, then sank by 73.97% to $259.4 million in 2024, then jumped by 411.68% to $1.3 billion in 2025, then surged by 50.68% to $2.0 billion in 2026.
• The last three Market Capitalization figures came in at $2.0 billion (Q2 2026), $1.5 billion (Q1 2026), and $1.3 billion (Q4 2025), per Business Quant data.